Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Titel:
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma
Auteur:
Raje, Noopur Kumar, Shaji Hideshima, Teru Ishitsuka, Kenji Chauhan, Dharminder Mitsiades, Constantine Podar, Klaus Le Gouill, Steven Richardson, Paul Munshi, Nikhil C. Stirling, David I. Antin, Joseph H. Anderson, Kenneth C.